Gabriel Braley
Pfizer (United States)(US)
Publications by Year
Research Areas
Cannabis and Cannabinoid Research, Neurotransmitter Receptor Influence on Behavior, Neuroscience and Neuropharmacology Research, Neuroscience of respiration and sleep, Forensic Toxicology and Drug Analysis
Most-Cited Works
- → The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis(2004)1,018 cited
- → Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study(2019)612 cited
- → Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction(2005)610 cited
- → Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of Cannabis(2008)260 cited
- → Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Δ-9-tetrahydrocannabinol in humans(2008)121 cited
- → The effects of cannabinoids on serum cortisol and prolactin in humans(2008)117 cited
- → Enhanced Sensitivity to the Euphoric Effects of Alcohol in Schizophrenia(2006)51 cited
- → The safety of studies with intravenous Δ9-tetrahydrocannabinol in humans, with case histories(2011)33 cited
- → Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans(2012)27 cited
- → A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity(2020)12 cited